Authorities announced 2,250 new cases in Switzerland on Friday in one day. The number of cases continues to increase in Switzerland, by 20% on a weekly basis.
■ More than 100 million vaccinated in the United States
More than 100 million people in the United States had received at least one dose of a vaccine against Covid-19 as of Friday, according to the Centers for Disease Prevention and Control, the main federal public health agency of the country.
In detail, more than 101.8 million people have received at least one injection of the vaccine, and 58 million people are fully vaccinated, including more than one in two people over 65 years.
People vaccinated against Covid-19 can resume travel by taking precautions, that is to say by wearing a mask and respecting physical distancing, US health authorities announced on Friday.
■ Back to the stadium in California
Sports fans and supporters of the various California basketball and ice hockey teams will once again be able to attend matches in the covered arenas starting April 15, in accordance with new guidelines from state authorities announced on Friday evening.
With the health situation linked to the Covid-19 pandemic improving, thanks to the massive and rapid vaccination underway, the California Department of Public Health has decided to allow private gatherings, events or meetings such as receptions or conferences, as well as sporting events and indoor shows.
The number of spectators allowed into theaters will vary depending on the Covid-19 situation in each county. California applies a four-level color scheme to each county, based on the number of cases identified.
■ AstraZeneca’s potion is intriguing again
Three new cases of blood clots associated with AstraZeneca’s Covid-19 vaccine, with two additional deaths, occurred in France between March 19 and 25.
Since the start of vaccination, there are “twelve cases, including four deaths in total” of these rare thromboses which have occurred in France, said the French Medicines Agency on Friday evening.
However, a sentence of this authority raises the doubt concerning the Swedish-English product. The ANSM considers that it is about “thromboses of the large veins atypical by their localization (cerebral in majority, but also digestive), being able to be associated with a thrombocytopenia (deficit in blood platelets, NDLR) or with disorders of coagulation “.
Two weeks ago, the Paul-Ehrlich medical institute, which advises the German government, was the first to point out “a striking accumulation of a specific form of very rare cerebral venous thrombosis, in connection with a deficiency of blood platelets. “. According to specialists, this very specific picture is reminiscent of a phenomenon called disseminated intravascular coagulation.
In a dispatch this Saturday morning, AFP recalls the words of Odile Launay, member of the Covid vaccine committee created by the French government; she considered that these are “quite exceptional syndromes, which will be seen in the context of serious sepsis” (severe infections) and can result “in both thrombosis and hemorrhaging”.
Next week, the European Medicines Agency will take up the issue again.